FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
686 letters match. Newest first.
-
DrugsMile High Compounds LLC
FDA warned Mile High Compounds that it sells unapproved injectable GLP-1-like drugs and BAC water online.
High risk -
DrugsPekCura Labs
FDA warned PekCura Labs that its GLP-1-S, GLP-2-T, GLP-3-R, and bacteriostatic water products are unapproved new drugs sold online.
High risk -
DrugsCitra100mg
FDA warns Citra100mg it sells unapproved, misbranded tramadol opioids without prescriptions to U.S. consumers online.
High risk -
DrugsGenoGenix LLC
FDA warns GenoGenix over insanitary sterile compounding, endotoxin-contaminated NAD+, and unapproved drugs.
High risk -
BiologicsDynamic Stem Cell Therapy
FDA warned Dynamic Stem Cell Therapy that its umbilical cord-derived stem cell product is an unapproved, unlicensed, misbranded biological drug.
High risk -
DrugsMedisourceRx
MedisourceRx failed to report a serious adverse event and had inadequate procedures, so its compounded drugs lost legal exemptions.
Medium -
DrugsBeach Weekend Management LLC dba Nic and Jet Fuel
FDA told Nic and Jet Fuel its nicotine energy drinks are unapproved new drugs sold with drug-like claims.
Medium -
DrugsAgebox Inc.
Agebox Inc. sells iKids-Growth children's supplements containing the undeclared, unapproved drug ibutamoren, making them unapproved and misbranded drugs.
High risk -
DrugsAtomix LLC
FDA warned Atomix LLC that its website sells unapproved SARM drugs MK-2866 and RAD-140 as new drugs without approval.
High risk -
DrugsPrime Sports Nutrition
FDA warns Prime Sports Nutrition that its website sells SARMs such as LGD-4033 and RAD-140 as unapproved new drugs.
High risk -
DrugsPinnacle Professional Research dba Pinnacle Peptides
FDA told Pinnacle Peptides its SARMs sold online are unapproved new drugs with serious safety risks.
High risk -
DrugsDynamic Health Group dba SARMS AMERICA
FDA told SARMS AMERICA its SARMs products (Ostarine, MK-677, Cardarine, LGD-4033) are unapproved new drugs sold online without FDA approval.
High risk -
DrugsTITAN SARMS LLC
Titan SARMS LLC sells SARM capsules (LGD-4033, RAD-140, S-4, YK-11) as unapproved new drugs, FDA says after website review.
High risk -
DrugsMusclepower Enterprise Ltd. dba MONSTER KING and GE LABS
FDA warned Musclepower Enterprise (MONSTER KING/GE LABS) over unapproved SARM drugs and undeclared trendione in GE Labs Ykarine.
High risk -
BiologicsCelularity, Inc
FDA warns Celularity that Interfyl is an unapproved new drug and unlicensed biological product marketed for orthopedic and wound uses.
High risk -
BiologicsBioXtek LLC
FDA says BioXtek's amniotic membrane products are unapproved new drugs and unlicensed biological products.
High risk -
BiologicsLux Therapeutics LLC dba Ponya Therapeutics LLC
FDA warns Lux Therapeutics over unvalidated TheraMend amniotic patches and records, citing inadequate response and Luxegen distribution concerns.
High risk -
DrugsVarunKart Group LLC dba Organic Wellnesses
VarunKart Group sells unapproved Ayurvedic and homeopathic drugs with serious disease claims.
High risk -
DrugsDistacart Inc.
FDA says Distacart's website sells unapproved drugs, some claimed for malaria, asthma, depression and eye conditions.
High risk -
DrugsSwift Digital Group LLC dba Swadesii
FDA warned Swadesii that its website sells unapproved drugs with claims to treat serious conditions including measles, cancer and Alzheimer's.
High risk -
DrugsHandelnine Global, LLC dba Navafresh
Navafresh sells unapproved Ayurvedic drugs online, and its Rheumacare Capsules contain about 7,000 times the lead level of concern.
High risk -
DrugsMahita LLC dba PushMyCart
FDA told online seller PushMyCart its website and Facebook posts sell unapproved drugs claiming to treat measles, cancer, diabetes and Parkinson's.
High risk -
Drugs123Herbals
FDA warned 123Herbals that SILINTAN and other herbal products are unapproved drugs, and SILINTAN contains hidden meloxicam.
High risk -
DrugsShoplet
FDA warned Shoplet over website sales of unapproved, misbranded triclosan antiseptic lotion soaps.
Medium -
DrugsSave Rite Medical
Save Rite Medical sold triclosan antiseptic lotion soaps online as unapproved, misbranded new drugs.
Medium -
DrugsMedical Mega
FDA: Medical Mega sells unapproved triclosan antiseptic soaps as nonprescription drugs.
Medium -
DrugsSinsin Pharmaceutical Co., Ltd.
FDA warned Sinsin Pharmaceutical that two Korean topical pain relievers sold in the US are unapproved and misbranded drugs.
High risk -
DrugsDermaRite Industries, LLC
DermaRite failed CGMP and sold unapproved, misbranded OTC topical drugs, FDA says.
High risk -
DrugsUriel Pharmacy, Inc.
Uriel Pharmacy's homeopathic ampule drugs are unapproved new drugs and were made under serious CGMP violations.
High risk -
DrugsKorea Filler Experts
FDA warned Korea Filler Experts that its website sells unapproved and misbranded injectable botulinum toxin drugs, including Nabota 100UI, to U.S. consumers.
High risk -
DrugsIBSPOT.com Inc.
FDA says IBSPOT.com sold unapproved motion sickness patches containing diphenhydramine and diclofenac that the labels never listed.
High risk -
DrugsCosmenic
FDA warned Panama-based Cosmenic that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsDermacare dba Filler Outlet
South Korea's Dermacare, doing business as Filler Outlet, sells unapproved, misbranded injectable botulinum toxin to U.S. consumers through its website.
High risk -
DrugsMaypharm
Maypharm website sells unapproved, misbranded Botulax botulinum toxin to U.S. consumers, FDA says.
High risk -
DrugsEstaderma
FDA warned South Korea's Estaderma that its website sells unapproved, misbranded injectable botulinum toxin (Liztox) to U.S. consumers.
High risk -
DrugsKorean Aesthetic dba Korean Fillers
FDA warned Korean Fillers that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsCelestaPro
FDA told CelestaPro its website sells unapproved, misbranded injectable botulinum toxin drugs, including "Nabota 200 Unit", to U.S. consumers.
High risk -
DrugsAceCosm
AceCosm’s website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
DrugsDermax Co., Ltd
FDA warned China's Dermax Co., Ltd. over its website selling unapproved, misbranded injectable botulinum toxin to U.S. consumers.
High risk -
DrugsGlow Nest Beauty
FDA warned Glow Nest Beauty that its website sells unapproved, misbranded injectable botulinum toxin Rentox 200U.
High risk -
DrugsAesthetic Essentials Limited
Hong Kong company Aesthetic Essentials Limited sells not-FDA-approved, mislabeled injectable botulinum toxin drugs online to U.S. consumers.
High risk -
DrugsElle Pharm
FDA warned Elle Pharm that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsCOSMO KOREA
FDA told South Korea's COSMO KOREA that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsGlam Derma
FDA warns Glam Derma over website selling unapproved, misbranded injectable botulinum toxin products.
High risk -
DrugsMeamo
Meamo's website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
DrugsMJS Medicals
FDA warned South Korea's MJS Medicals for selling unapproved, misbranded botulinum toxin ("Innotox") to U.S. consumers online.
High risk -
DrugsDerma Solution
FDA warned Derma Solution for selling unapproved, misbranded injectable Botulax botulinum toxin drugs online to U.S. consumers.
High risk -
DrugsGlowface
Glowface's website sells unapproved, misbranded injectable Botulax botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
Drugsonlineotcmeds.com
FDA warned onlineotcmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants to U.S. consumers online.
High risk -
Drugswww.usmedschoice.com
FDA warned www.usmedschoice.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants online without prescriptions.
High risk